Donckier V, Flamand V, Desalle F, Vanderhaeghen M L, de Veerman M, Thielemans K, Abramowicz D, Goldman M
Laboratory of Experimental Immunology, Université Libre des Bruxelles, Brussels, Belgium.
Eur J Immunol. 1998 Apr;28(4):1426-30. doi: 10.1002/(SICI)1521-4141(199804)28:04<1426::AID-IMMU1426>3.0.CO;2-P.
We investigated the effect of IL-12 on the induction of transplantation tolerance by neonatal injection of allogenic cells. We first observed that injection of newborn BALB/c mice with IL-12 and (A/J x BALB/c)F1 spleen cells prevented the Th2 alloimmune response induced by neonatal inoculation of F1 cells alone and allowed the differentiation of T cells secreting high amounts of IL-2 and IFN-gamma in mixed lymphocyte cultures with donor-type stimulators. Furthermore, IL-12 administration resulted in the emergence of anti-donor cytotoxic T lymphocyte responses although at lower levels than in control uninjected mice. In parallel, we found that mice injected at birth with IL-12 and F1 cells did not develop chimerism and were able to reject a donor-type skin graft as efficiently as control mice. We conclude that IL-12 inhibits the Th2 polarization of the newborn response to alloantigens and prevents thereby the establishment of transplantation tolerance.
我们研究了白细胞介素-12(IL-12)对新生小鼠注射同种异体细胞诱导移植耐受的影响。我们首先观察到,给新生BALB/c小鼠注射IL-12和(A/J×BALB/c)F1脾细胞,可预防单独新生接种F1细胞所诱导的Th2同种免疫反应,并允许在与供体型刺激物的混合淋巴细胞培养物中分泌大量白细胞介素-2(IL-2)和γ干扰素(IFN-γ)的T细胞分化。此外,给予IL-12导致抗供体细胞毒性T淋巴细胞反应的出现,尽管其水平低于未注射对照小鼠。同时,我们发现出生时注射IL-12和F1细胞的小鼠未形成嵌合体,并且能够像对照小鼠一样有效地排斥供体型皮肤移植。我们得出结论,IL-12抑制新生小鼠对同种异体抗原反应的Th2极化,从而阻止移植耐受的建立。